ACO Name and Location
HHC ACO Inc.
50 Water Street, 3rd Floor
New York, NY 10004
ACO Primary Contact
Matthew Siegler
212-788-3479
SieglerM@nychhc.org
Organizational Information
ACO participants:
| ACO Participants | ACO Participant in Joint Venture |
| Community Healthcare Network, Inc. | Y |
| Coney Island Medical Practice Plan, P.C. | Y |
| Downtown Bronx Medical Associates, P.C. | Y |
| Harlem Medical Associates, P.C. | Y |
| Icahn School of Medicine at Mount Sinai (DBA: Mount Sinai Elmhurst Faculty Practice Group) | Y |
| Metropolitan Medical Practice Plan, P.C. | Y |
| New York City Health and Hospitals Corporation | Y |
ACO governing body:
| Member | |||||
| Last name | First Name | Title/Position | Member’s Voting Power – Expressed as a percentage or number | Membership Type | ACO Participant Legal Business Name/DBA, if Applicable |
| Katz | Mitchell | Chair | 1 | ACO Participant Representative | New York City Health and Hospitals Corporation |
| Siegler | Matthew | CEO | 1 | ACO Participant Representative | New York City Health and Hospitals Corporation |
| Kalkut | Gary | Vice President | 1 | ACO Participant Representative | New York City Health and Hospitals Corporation |
| Ulberg, Jr. | John E. | Treasurer | 1 | ACO Participant Representative | New York City Health and Hospitals Corporation |
| Cohen | Andrea | Secretary | 1 | ACO Participant Representative | New York City Health and Hospitals Corporation |
| Jordan-Martin | Nicole | Voting Member | 1 | ACO Participant Representative | New York City Health and Hospitals Corporation |
| Napolitano | Daniel | Voting Member | 1 | ACO Participant Representative | Community Healthcare Network, Inc. |
| Becker | Richard | Voting Member | 1 | Other | |
| Moshirpur | Jasmin | Voting Member | 1 | ACO Participant Representative | Icahn School of Medicine at Mount Sinai (DBA: Mount Sinai Elmhurst Faculty Practice Group) |
| Peart | Hyacinth | Voting Member | 1 | Medicare Beneficiary Representative | |
| Seigel | Warren | Voting Member | 1 | ACO Participant Representative | Coney Island Medical Practice Plan, P.C. |
Key ACO clinical and administrative leadership:
ACO Executive: Matthew Siegler
Chief Medical Officer: David Stevens, MD
Compliance Officer: Catherine Patsos, Esq.
Quality Assurance/Improvement Officer: David Stevens, MD
Associated committees and committee leadership:
| Committee Name | Committee Leader Name and Position |
| Governance Committee | Mitchell Katz, MD, Board Chair |
| Clinical Leadership & Quality Assurance Committee | David Stevens, MD, Medical Director |
| Audit Committee | John Ulberg, MPH, Treasurer |
Types of ACO participants, or combinations of participants, that formed the ACO:
- ACO professionals in a group practice arrangement
- Hospital employing ACO professionals
- Partnerships or joint venture arrangements between hospitals and ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses
- Third Agreement Period
- Performance Year 2021, $4,007,011
- Performance Year 2020, $11,415,299
- Performance Year 2019, $4,621,337
- Second Agreement Period
- Performance Year 2019, $4,621,337
- Performance Year 2018, $2,967,275
- Performance Year 2017, $2,182,360
- Performance Year 2016, $1,586,859
- First Agreement Period
- Performance Year 2015, $6,052,364
- Performance Year 2014, $2,644,605
- Performance Year 2013, $3,639,766
Shared Savings Distribution
- Third Agreement Period
- Performance Year 2021
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 42%
- Proportion of distribution to ACO participants: 58%
- Performance Year 2020
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 42%
- Proportion of distribution to ACO participants: 58%
- Performance Year 2019
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 42%
- Proportion of distribution to ACO participants: 58%
- Performance Year 2021
- Second Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 42%
- Proportion of distribution to ACO participants: 58%
- Performance Year 2018
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 48%
- Proportion of distribution to ACO participants: 52%
- Performance Year 2017
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 57%
- Proportion of distribution to ACO participants: 43%
- Performance Year 2016
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 85%
- Proportion of distribution to ACO participants: 15%
- Performance Year 2019
- First Agreement Period
- Performance Year 2015
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 20%
- Proportion of distribution to ACO participants: 80%
- Performance Year 2014
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 28%
- Proportion of distribution to ACO participants: 72%
- Performance Year 2013
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 36%
- Proportion of distribution to ACO participants: 64%
- Performance Year 2015
Quality Performance Results
2021 Quality Performance Results:
| Measure # | Measure Name | Rate | ACO Mean |
| 318 | Falls: Screening for Future Fall Risk | 73.12 | 87.03 |
| 110 | Preventive Care and Screening: Influenza Immunization | 71.31 | 80.52 |
| 226 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 76.47 | 80.97 |
| 134 | Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan | 80.22 | 74.38 |
| 113 | Colorectal Cancer Screening | 68.32 | 73.63 |
| 112 | Breast Cancer Screening | 67.79 | 75.11 |
| 438 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | 89.62 | 84.24 |
| 001 | Diabetes Mellitus: Hemoglobin A1c Poor Control (<9%) | 14.88 | 12.46 |
| 236 | Controlling High Blood Pressure | 67.31 | 74.87 |
| 321 | CAHPS for MIPS | N/A | N/A |
| 479 | Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups | 0.1762 | 0.1540 |
| MCC1 | All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs | 45.15 | 33.99 |
For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.
Payment Rule Waivers
- Waiver for Payment for Telehealth Services:
- Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR §425.612(f) and 42 CFR §425.613.